
Sign up to save your podcasts
Or


Dr. Jim Mault, BioIntellisense CEO, breaks down the rise of remote patient monitoring and explains why it’s time to drop the term. He also speaks about his time at Microsoft and Qualcomm.
By Informa Markets4.9
77 ratings
Dr. Jim Mault, BioIntellisense CEO, breaks down the rise of remote patient monitoring and explains why it’s time to drop the term. He also speaks about his time at Microsoft and Qualcomm.

112,426 Listeners